[Schizophrenia as a dopamine excess syndrome].
D000368:Aged; D000662:Amphetamines / Q000009:adverse effects; D000818:Animals; D001921:Brain / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism*; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D008297:Male; D011605:Psychoses, Substance-Induced / Q000378:metabolism; D051381:Rats; D011954:Receptors, Dopamine / Q000378:metabolism; D012559:Schizophrenia / Q000188:drug therapy / Q000378:metabolism*; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism
D000662:Amphetamines; D011954:Receptors, Dopamine; D014446:Tyrosine 3-Monooxygenase; D006220:Haloperidol; D004298:Dopamine